Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Monobutyrin** is a monoglyceride formed by the esterification of *butyric acid* with one of the primary hydroxyl groups of *glycerol*. Naturally found in butter and cod liver oil, it is most commonly used as a feed and food additive due to its lipid-regulating, antibacterial, and gut barrier-promoting properties[1][2][3][5][6]. Monobutyrin is bioactive and more stable than free butyric acid with reduced volatility and odor[1][2]. In animal and preclinical studies, monobutyrin has been shown to: - Improve lipid metabolism and lower hepatic lipid accumulation, partly by activation of the peroxisome proliferator-activated receptor alpha (PPARα) signaling pathway[1]. - Enhance intestinal barrier integrity by promoting villi growth, tight-junction development, and modulating immune cell populations (increasing regulatory T cells and Th17 cells in the intestine)[5]. - Have broad-spectrum antibacterial activity against enteric pathogens (e.g., *E. coli*, *Salmonella*, *Clostridium*, *Brachispira*, *Lawsonia*) that is pH-independent, promoting its use as an alternative to antibiotics in animal husbandry[3][9]. - Modulate gut microbiota composition, increasing beneficial bacteria such as *Lactobacillus*, and support healthy microbiota development in weaned animals[1][5][7]. - Act as an angiogenic factor secreted by differentiating adipocytes and support blood vessel formation[2]. Mechanistically, monobutyrin is absorbed in the intestine and may be metabolized through glycerol kinase and glycerol-3-phosphate dehydrogenase pathways, thereby reducing lipid deposition and supporting metabolic health[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on monobutyrin.